Peninsula biotech to cut 30 jobs as it shuts down one hepatitis B to focus on others

The company is cutting its first-generation hepatitis B virus inhibitor program but is prioritizing two other potential hep B therapies.

Source: bizjournals.com Health Care News Headlines - July 20, 2022 Category: Health Management Authors: Ron Leuty Source Type: news